Abstract:Objective To explore the mechanism of carbachol treatment for multiple organ dysfunction syndrome (MODS) in the aspect of regulating dendritic cells (DC) activity. Methods Sepsis(MODS) mice model was established by intraperitoneal injection of zymosan. Male C57BL/6 mice were randomly divided into normal control (n=10), zymosan challenge 6, 24 and 48 hours (30 each), and zymosan challenge+carbachol 6, 24 and 48 hours groups (30 each). All the mice received normal saline by gavage before intraperitoneaI injection of zymosan. Mice of zymosan challenge+carbachol group received carbachol by gavage 3 times per day prior to injection of zymosan. Changes in DC phenotype were analyzed by flow cytometry. The expression of IL-1β was measured by immunochistochemistry method. IL-12 p70 was determined by ELISA. Results In zymosan challenge groups, the number of mature DC in spleen increased in 6 and 24-hour groups, and declined to normal level in 48-hour group. The numbers of IL-1β positive cells increased significantly in 6 and 24-hour groups, and declined to normal level in 48-hour group. The levels of IL-12p70 in spleen showed a similar fluctuation as that of the IL-1β positive cells and mature DC. While in carbachol treatment groups, the numbers of mature DC and IL-1β positive cells decreased in spleen, and IL-12p70 decreased to normal level. Conclusion Carbachol may interrupt the development of septic syndome and MODS by suppressing the maturation of DCs and attenuating inflammatory reaction in the early stage.

Effects of Carbachol on the Splenic Dendritic Cells in Early Stage of MODS in Mice